Delaware Valley Medical provides drug and alcohol treatment from its location at 7980 South Crescent Boulevard Route 130 in Merchantville, New Jersey. It is a private provider.
Levels of care offered here include intensive outpatient (IOP), standard outpatient counseling, medication-assisted treatment (MAT), a federally certified opioid treatment program, co-occurring (dual diagnosis) mental health treatment, and telehealth therapy. Clinicians use approaches such as anger management, brief intervention, cognitive behavioral therapy, contingency management/motivational incentives, and community reinforcement plus vouchers. For opioid use disorder, the program uses methadone, buprenorphine, and naltrexone. It also prescribes medication for alcohol use disorder.
Payment options include government funding for substance use treatment, Medicare, Medicaid, private health insurance, cash or self-payment, and state-financed health insurance plan other than Medicaid. A sliding fee scale based on income is available. Coverage depends on your specific plan, so verify benefits before admission.
The program accepts young adults, adults, and seniors. It offers specialized groups for pregnant/postpartum women, clients with co-occurring mental and substance use disorders, clients with co-occurring pain and substance use disorders, and clients who have experienced trauma. Services are available in Spanish.
Delaware Valley Medical is accredited by Commission on Accreditation of Rehabilitation Facilities (CARF) and licensed or certified by the state substance use treatment agency, state department of health, and SAMHSA certification for opioid treatment program (OTP).
Support services include aftercare/continuing care, discharge planning, naloxone and overdose education, and outcome follow-up after discharge.